Tags |
|
|
Links |
|
|
Advice You - Social Networking Websites Popularity May Be Short Lived
A lot of people are jumping on the Myspace bandwagon by creat
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ing their own social networking websites to appeal to differe
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
t niches within different demographics. Myspace is a place fo
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
r everyone, now web programmers and developers are narrowing
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
heir focus because they know a niche can make them rich.
Due
Due
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
to this increase in social networking websites a lot of peop
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
e are calling this another internet boom. People are creating
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
social networking websites for a few hundred dollars and get
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ing big offers from venture capitalists to sell their website
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s for millions of dollars. The main reason venture capitalist
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
want to purchase these companies is because they know the ad
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
vertising revenue from these companies can be very high. The
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
nder thirty market is a difficult market to reach but social
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
networking websites put a lot of people all in one place, mak
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ng it easier for advertisers.
Even though people are making
Even though people are making
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
social networking websites, and others are willing to buy the
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
, the bad publicity that they get for being unsafe, as well a
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
s a future saturation of the market, from too many people sta
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ting social networking websites, is going to leave some peopl
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e that try to jump in on this new internet bubble in the cold
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/81002/adviceyou-Social-Networking-Websites-Popularity-May-Be-Short-Lived.html">Social Networking Websites Popularity May Be Short Lived</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/81002/adviceyou-Social-Networking-Websites-Popularity-May-Be-Short-Lived.html]Social Networking Websites Popularity May Be Short Lived[/url]
Related Articles:
Totally Free Classifieds Website - Anything Can Happen If Someone is Truly Motivated
Using Blog PR to Promote Your Site
Bookmark it:
|